{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "1719783", "DateCompleted": {"Year": "1991", "Month": "12", "Day": "23"}, "DateRevised": {"Year": "2019", "Month": "08", "Day": "24"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0065-4299", "JournalIssue": {"Volume": "33", "Issue": "3-4", "PubDate": {"Year": "1991", "Month": "Jul"}}, "Title": "Agents and actions", "ISOAbbreviation": "Agents Actions"}, "ArticleTitle": "Inhibition of rat paw oedema and pleurisy by the extract from Mandevilla velutina.", "Pagination": {"StartPage": "272", "EndPage": "278", "MedlinePgn": "272-8"}, "Abstract": {"AbstractText": ["This study reports the oral anti-inflammatory profile of the crude extract (CE) of Mandevilla velutina, a plant which has been previously demonstrated to selectively antagonize bradykinin response of the isolated tissues on rat paw oedema and pleurisy caused by different phlogistic agents. The CE (50 to 200 mg/kg), given 60 min before, inhibited in a dose-dependent manner bradykinin (BK) and cellulose sulphate-induced paw oedema, maximal inhibition of 59% and 65%, respectively. In the same range dose the CE also significantly antagonized pleural exudate and cell infiltration caused by these substances, maximal inhibition of 34% and 46%, respectively. In addition, the CE (100 and 200 mg/kg) also inhibited paw oedema induced by serotonin, PAF-acether and zymosan, maximal inhibition of 55%, 38% and 46%, respectively, but enhanced histamine oedema. However, the CE revealed only partial or no inhibition in pleural exudate caused by these agents. The CE (100 and 200 mg/kg) also inhibited in a dose and time-dependent manner carrageenan-induced paw oedema with a maximal inhibition of 44%, but only partially affected carrageenan-induced pleural exudate. The CE also partially inhibited dextran oedema, but even at a higher dose (400 mg/kg) it failed to interfere with Bothrops Jaracaca-induced paw oedema. The CE inhibited BK and to a lesser extent cellulose sulphate-induced cell migration, but failed to interfere with the differential leukocyte migration in the pleural cavity. These findings provide evidence that the CE from M. velutina, besides antagonizing kinin action, exhibit an oral anti-oedematogenic activity against a variety of phologistic agents, but it was more effective in inhibiting those models where kinins are more involved."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departamento de Fisiologia e Farmacodin\u00e2mica, Funda\u00e7\u00e3o Oswaldo Cruz, Rio de Janeiro, Brazil."}], "LastName": "Henriques", "ForeName": "M G", "Initials": "MG"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Fernandes", "ForeName": "P D", "Initials": "PD"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Weg", "ForeName": "V B", "Initials": "VB"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Yunes", "ForeName": "R A", "Initials": "RA"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Cordeiro", "ForeName": "R S", "Initials": "RS"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Calixto", "ForeName": "J B", "Initials": "JB"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Agents Actions", "NlmUniqueID": "0213341", "ISSNLinking": "0065-4299"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Dextrans"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "9000-07-1", "NameOfSubstance": "Carrageenan"}, {"RegistryNumber": "9004-34-6", "NameOfSubstance": "Cellulose"}, {"RegistryNumber": "9032-43-3", "NameOfSubstance": "cellulose sulfate"}, {"RegistryNumber": "S8TIM42R2W", "NameOfSubstance": "Bradykinin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Bradykinin"}, {"QualifierName": [], "DescriptorName": "Brazil"}, {"QualifierName": [], "DescriptorName": "Carrageenan"}, {"QualifierName": ["analogs & derivatives"], "DescriptorName": "Cellulose"}, {"QualifierName": [], "DescriptorName": "Dextrans"}, {"QualifierName": ["chemically induced", "prevention & control"], "DescriptorName": "Edema"}, {"QualifierName": ["metabolism"], "DescriptorName": "Exudates and Transudates"}, {"QualifierName": ["pathology"], "DescriptorName": "Foot"}, {"QualifierName": [], "DescriptorName": "Leukocyte Count"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["chemically induced", "prevention & control"], "DescriptorName": "Pleurisy"}, {"QualifierName": [], "DescriptorName": "Rats"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Am J Physiol. 1949 Feb;156(2):261-73", "ArticleIdList": ["18127230"]}, {"Citation": "Gen Pharmacol. 1983;14(2):209-29", "ArticleIdList": ["6132853"]}, {"Citation": "Braz J Med Biol Res. 1988;21(5):1015-8", "ArticleIdList": ["3248229"]}, {"Citation": "Br J Pharmacol. 1970 Jan;38(1):214-20", "ArticleIdList": ["4391733"]}, {"Citation": "Agents Actions. 1989 Mar;26(3-4):292-300", "ArticleIdList": ["2660497"]}, {"Citation": "J Exp Med. 1980 Aug 1;152(2):324-35", "ArticleIdList": ["7400759"]}, {"Citation": "Br J Pharmacol. 1986 Aug;88(4):937-41", "ArticleIdList": ["3742164"]}, {"Citation": "Br J Pharmacol Chemother. 1965 Feb;24:163-9", "ArticleIdList": ["14302350"]}, {"Citation": "Clin Pharmacol Ther. 1988 Dec;44(6):613-21", "ArticleIdList": ["3197362"]}, {"Citation": "Br J Pharmacol. 1989 Feb;96(2):363-71", "ArticleIdList": ["2924083"]}, {"Citation": "Br J Pharmacol. 1971 Jul;42(3):392-402", "ArticleIdList": ["4104654"]}, {"Citation": "J Pathol. 1971 May;104(1):15-29", "ArticleIdList": ["4398139"]}, {"Citation": "J Pharm Pharmacol. 1979 Sep;31(9):648", "ArticleIdList": ["41077"]}, {"Citation": "Br J Pharmacol Chemother. 1968 Jul;33(3):501-12", "ArticleIdList": ["4178154"]}, {"Citation": "Gen Pharmacol. 1988;19(4):595-9", "ArticleIdList": ["3410281"]}, {"Citation": "Prostaglandins. 1991 May;41(5):515-26", "ArticleIdList": ["1907393"]}, {"Citation": "Br J Pharmacol. 1987 May;91(1):199-204", "ArticleIdList": ["3594076"]}, {"Citation": "Gen Pharmacol. 1990;21(3):285-90", "ArticleIdList": ["2341013"]}, {"Citation": "Pharmacol Res Commun. 1987 Dec;19(12):859-76", "ArticleIdList": ["3448610"]}, {"Citation": "Br J Pharmacol. 1985 Aug;85(4):729-31", "ArticleIdList": ["4041675"]}, {"Citation": "Eur J Pharmacol. 1989 Nov 21;171(2-3):259-63", "ArticleIdList": ["2482813"]}, {"Citation": "J Pharm Pharmacol. 1974 Jun;26(6):434-40", "ArticleIdList": ["4154988"]}, {"Citation": "Br J Pharmacol. 1988 Aug;94(4):1133-42", "ArticleIdList": ["3207977"]}, {"Citation": "Biochem J. 1978 Nov 15;176(2):433-42", "ArticleIdList": ["743251"]}, {"Citation": "J Pharmacol Exp Ther. 1988 Aug;246(2):635-40", "ArticleIdList": ["3136243"]}, {"Citation": "J Biol Chem. 1982 Feb 25;257(4):1591-4", "ArticleIdList": ["6799509"]}, {"Citation": "J Pharm Pharmacol. 1968 Jan;20(1):77-8", "ArticleIdList": ["4384156"]}, {"Citation": "Annu Rev Immunol. 1988;6:49-83", "ArticleIdList": ["3289575"]}, {"Citation": "Nature. 1966 Dec 17;212(5068):1364", "ArticleIdList": ["5967019"]}], "ReferenceList": []}], "History": [{"Year": "1991", "Month": "7", "Day": "1"}, {"Year": "1991", "Month": "7", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1991", "Month": "7", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["1719783", "10.1007/BF01986573"]}}]}